Research Article

Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size

Table 3

Predictors of DFS in NSCLC patients.

VariableUnivariate analysisMultivariate analysis
HR95CIPHR95CIP

Age group (≤50 /50-65/≥65 years old)0.5050.292-0.8710.0140.2720.141-0.5250.000
ECOG (=0/1/2)1.9360.877-4.2760.1025.1611.932-13.7910.001
lymphatic metastasis(≥5/<5)0.0430.-4536.4820.5954.1011.531-10.9890.005
BMI(<20/20-24/>24)0.3510.145-0.8510.0210.2590.91-0.7340.011
Occupation (peasant/ worker/ cadre/ intellectual)1.4830.549-4.0050.4374.4261.274-15.3810.019
KPS (<80/≥80)0.4710.235-0.9430.034
Smoke (no/yes)1.2600.811-1.9570.303
Tumor size (≥5/<5)1.1150.570-2.1800.750
Clinical stages (IIA /IIB/IIIA)1.1390.748-1.7350.543
Treatment (TCM user/non-TCM user)0.4090.200-0.8370.014